A new market study, titled “Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2025”, has been featured on WiseGuyReports.
This report studies the global Hepatitis B and C Diagnostics market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Hepatitis B and C Diagnostics market by companies, region, type and end-use industry.
Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.
The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.
Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.
This report focuses on the global top players, covered
Roche Diagnostics
Abbott
Siemens
Qiagen
Alere
bioMérieux
Cepheid
Chembio Diagnostics
DiaSorin
Enzo Life Sciences
Hologic
MedMira
OraSure Technologies
Quest Diagnostics
Quidel Corp
Randox Laboratories
Request Sample Report at https://www.wiseguyreports.com/sample-request/3329375-global-hepatitis-b-and-c-diagnostics-market-size-status-and-forecast-2025
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Market segment by Type, the product can be split into
Hepatitis B
Hepatitis C
Market segment by Application, split into
Immunodiagnostics
Nucleic Acid Test (NAT)
The study objectives of this report are:
To study and forecast the market size of Hepatitis B and C Diagnostics in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast between China and major regions, namely, United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Hepatitis B and C Diagnostics Manufacturers
Hepatitis B and C Diagnostics Distributors/Traders/Wholesalers
Hepatitis B and C Diagnostics Subcomponent Manufacturers
Industry Association
Downstream Vendors
Table of Contents
1 Industry Overview of Hepatitis B and C Diagnostics
2 Global Hepatitis B and C Diagnostics Competition Analysis by Players
3 Company (Top Players) Profiles
4 Global Hepatitis B and C Diagnostics Market Size by Type and Application (2013-2018)
5 United States Hepatitis B and C Diagnostics Development Status and Outlook
6 Europe Hepatitis B and C Diagnostics Development Status and Outlook
7 China Hepatitis B and C Diagnostics Development Status and Outlook
8 Japan Hepatitis B and C Diagnostics Development Status and Outlook
9 Southeast Asia Hepatitis B and C Diagnostics Development Status and Outlook
10 India Hepatitis B and C Diagnostics Development Status and Outlook
11 Market Forecast by Regions, Type and Application (2018-2025)
12 Hepatitis B and C Diagnostics Market Dynamics
13 Market Effect Factors Analysis
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)